Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: A randomised placebo-controlled study (REACTT)

European Urology

Volumn 65, Issue 3, 2014, Pages 587-596

  Montorsi, Francesco ^a   Brock, Gerald ^b   Stolzenburg, Jens Uwe ^c   Mulhall, John ^d   Moncada, Ignacio ^e   Patel, Hitendra R H ^f   Chevallier, Daniel ^g   Krajka, Kazimierz ^h   Henneges, Carsten ⁱ   Dickson, Ruth ^j   Büttner, Hartwig ⁱ  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e HOSPITAL LA ZARZUELA   (Spain)

^f UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^g CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^h Uniwersyteckie Centrum Kliniczne   (Poland)

ⁱ LILLY DEUTSCHLAND GMBH   (Germany)

^j ELI LILLY AND COMPANY   (United States)

more..

Author keywords

Clinical trials; Erectile dysfunction; Nerve sparing prostatectomy; Penile function; Phosphodiesterase type 5 inhibitors; Prostate cancer; Radical prostatectomy; Rehabilitation; Tadalafil once a day

Indexed keywords

CLINICAL TRIALS; ERECTILE DYSFUNCTION; NERVE-SPARING PROSTATECTOMY; PENILE FUNCTION; PHOSPHODIESTERASE TYPE 5 INHIBITORS; PROSTATE CANCER; RADICAL PROSTATECTOMY; REHABILITATION; TADALAFIL ONCE A DAY;

ADENOCARCINOMA; AGED; CARBOLINES; DOUBLE-BLIND METHOD; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; ORGAN SPARING TREATMENTS; PENILE ERECTION; PENIS; PHOSPHODIESTERASE 5 INHIBITORS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECOVERY OF FUNCTION;

EID: 84894433351     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.09.051     Document Type: Article

References (29)

1. Heidenreich A, Bastian PJ, Bellmunt J, et al. Guidelines on prostate cancer. European Association of Urology Web site. http://www.uroweb.org/gls/pdf/ 08%20Prostate%20Cancer-LR%20March%2013th%202012.pdf. Accessed June 27, 2013.
2. A. Salonia, A.L. Burnett, and M. Graefen et al. Prevention and management of postprostatectomy sexual dysfunctions. Part 1: choosing the right patient at the right time for the right surgery Eur Urol 62 2012 261 272
3. A. Salonia, A.L. Burnett, and M. Graefen et al. Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function Eur Urol 62 2012 273 286
4. V. Ficarra, G. Novara, and T.E. Ahlering et al. Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy Eur Urol 62 2012 418 430
5. F. Montorsi, P.H. Nathan, and A. McCullough et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial J Urol 172 2004 1036 1041 (Pubitemid 39096457)
6. K. Hatzimouratidis, A.L. Burnett, D. Hatzichristou, A.R. McCullough, F. Montorsi, and J.P. Mulhall Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application Eur Urol 55 2009 334 347
7. P.H. Nathan, A.R. McCullough, and L.A. Levine et al. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy Int J Impot Res 20 2008 479 486
8. F. Montorsi, G. Brock, and J. Lee et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy Eur Urol 54 2008 924 931
9. J.P. Mulhall, A.L. Burnett, and R. Wang et al. A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy J Urol 189 2013 2229 2236
10. J.C. Cappelleri, R.C. Rosen, M.D. Smith, A. Mishra, and I.H. Osterloh Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function Urology 54 1999 346 351 (Pubitemid 29367263)
11. G. Salomon, H. Isbarn, and L. Budaeus et al. Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy J Sex Med 6 2009 498 504
12. C. Nelson, H.H. Alphs, and F. Rabbani et al. Insights into the impact of nerve-sparing status during radical prostatectomy: validation of a nerve sparing scoring system J Urol 181 Suppl 4 2009 370
13. J.P. Mulhall, I. Goldstein, A.G. Bushmakin, J.C. Cappelleri, and K. Hvidsten Validation of the erection hardness score J Sex Med 4 2007 1626 1634 (Pubitemid 47616853)
14. A. Briganti, A. Gallina, and N. Suardi et al. What is the definition of a satisfactory erectile function after bilateral nerve sparing radical prostatectomy? J Sex Med 8 2011 1210 1217
15. M.D. Munding, H.B. Wessells, and B.L. Dalkin Pilot study of changes in stretched penile length 3 months after radical retropubic prostatectomy Urology 58 2001 567 569 (Pubitemid 32904499)
16. R.C. Rosen, K.R. Allen, X. Ni, and A.B. Araujo Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale Eur Urol 60 2011 1010 1016
17. A.B. Araujo, K.R. Allen, N. Xiao, and R.C. Rosen Minimal clinically important differences in the Vaginal Insertion and Successful Intercourse items of the Sexual Encounter Profile J Sex Med 9 2012 169 179
18. D. Machin, M.J. Campbell, P. Fayers, and A. Pinol Statistical tables for the design of clinical studies ed. 3. 1998 Blackwell Oxford, UK
19. A. Dmitrienko, F. Bretz, and P.H. Westfall et al. Multiple testing methodology A. Dmitrienko, A.C. Tamhane, F. Bretz, Multiple testing problems in pharmaceutical statistics 2009 Chapman and Hall/CRC Press New York, NY 35 98
20. A. Briganti, E. Di Trapani, and F. Abdollah et al. Choosing the best candidates for penile rehabilitation after bilateral nerve-sparing radical prostatectomy J Sex Med 9 2012 608 617
21. C.J. Nelson, P.T. Scardino, J.A. Eastham, and J.P. Mulhall Back to baseline: erectile function recovery after radical prostatectomy from the patients' perspective J Sex Med 10 2013 1636 1643
22. S.T. Forgue, B.E. Patterson, and A.W. Bedding et al. Tadalafil pharmacokinetics in healthy subjects Br J Clin Pharmacol 61 2006 280 288 (Pubitemid 43382627)
23. J. Angulo, M. Gadau, and A. Fernandez et al. IC351 enhances nitric oxide-mediated relaxation of human arterial and trabecular penile smooth muscle [] Diabetologia 44 2001 A295
24. S.A. Ballard, C.J. Gingell, K. Tang, L.A. Turner, M.E. Price, and A.M. Maylor Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes J Urol 159 1998 2164 2171 (Pubitemid 29190800)
25. J.S. Vasconcelos, R.T. Figueiredo, F.L. Nascimento, R. Damião, and E.A. da Silva The natural history of penile length after radical prostatectomy: a long-term prospective study Urology 80 2012 1293 1296
26. M.E. Mostafa, A.M. Senbel, and T. Mostafa Effect of chronic low-dose tadalafil on penile cavernous tissues in diabetic rats Urology 81 2013 1253 1260
27. K. Park, K.S. Ryu, W.J. Li, S.W. Kim, and J.S. Paick Chronic treatment with a type 5 phosphodiesterase inhibitor suppresses apoptosis of corporal smooth muscle by potentiating Akt signalling in a rat model of diabetic erectile dysfunction Eur Urol 53 2008 1282 1289
28. Berookhim BM, Nelson CJ, Kunzel B, Mulhall JP, Narus JB. A Prospective Analysis of Penile Length Changes Following Radical Prostatectomy. British J Urol Int. In press. http://dx.doi.org/10.1111/bju.12443.
29. E.J. Schwartz, P. Wong, and R.J. Graydon Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy J Urol 171 2004 771 774 (Pubitemid 38090480)